Medpace Holdings, Inc. (MEDP) PS Ratio: 4.98
Is Medpace Holdings, Inc.’s P/S ratio high or low?
Medpace Holdings, Inc.'s P/S ratio of 4.98 is in line with its 5-year average of 5.45, near the low end of its 5-year range (3.80–7.82).
As of Saturday, June 20, 2026. 18.20% below its 12-month average of 6.09.
MEDP PS Ratio Chart
MEDP Average PS Ratio Chart
MEDP Current vs Average PS Ratio Chart
MEDP PS Ratio Metrics
PS RATIO
4.98
PS RATIO AVG TTM
6.09
PS RATIO AVG 3Y
5.64
PS RATIO AVG 5Y
5.45
PS RATIO AVG 10Y
4.64
PS RATIO AVG 15Y
N/A
PS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-18.20%
CURRENT VS 3Y AVG
-11.66%
CURRENT VS 5Y AVG
-8.70%
CURRENT VS 10Y AVG
+7.37%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
MEDP Competitors' PS Ratio
| NAME | MARKET CAP | PS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Medpace Holdings, Inc. (MEDP) | $13.14B | 4.98 | 6.09 | 5.64 | 5.45 |
| Solventum Corporation (SOLV)vs › | $13.06B | 1.60 | 1.56 | 1.48 | 1.48 |
| Align Technology, Inc. (ALGN)vs › | $13.04B | 3.18 | 2.94 | 4.26 | 6.08 |
| DaVita Inc. (DVA)vs › | $13.34B | 1.04 | 0.83 | 0.91 | 0.89 |
| The Cooper Companies, Inc. (COO)vs › | $12.85B | 3.04 | 3.54 | 4.49 | 5.08 |
| Revvity, Inc. (RVTY)vs › | $11.16B | 3.85 | 3.93 | 4.57 | 4.63 |
| Walgreens Boots Alliance, Inc. (WBA)vs › | $10.37B | 0.07 | 0.06 | 0.13 | 0.20 |
| Baxter International Inc. (BAX)vs › | $10.27B | 0.90 | 0.99 | 1.30 | 1.79 |
| Hologic, Inc. (HOLX)vs › | $16.97B | 4.16 | 3.83 | 4.27 | 3.99 |
| Zimmer Biomet Holdings, Inc. (ZBH)vs › | $17.02B | 2.05 | 2.31 | 2.88 | 3.21 |
P/S vs. its own history
At 4.98, P/S is in its normal range, sitting higher than 62% of its 10-year history.
10-year low
2.15
median
4.52
10-year high
7.90
Sales Valuation
P/S Ratio
4.98
Market Cap / Annual Revenue
Medpace Holdings, Inc. PS Ratio Formula & Definition
PS Ratio = Market Cap / Revenue (TTM)
The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Medpace Holdings, Inc. PS Ratio FAQ
- What is the P/S ratio for Medpace Holdings, Inc. (MEDP)?
- The P/S ratio for MEDP stock is 4.98.
- Is Medpace Holdings, Inc.'s P/S ratio high or low?
- Medpace Holdings, Inc.'s P/S ratio of 4.98 is in line with its 5-year average of 5.45, near the low end of its 5-year range (3.80–7.82).
- What is the TTM average P/S ratio for Medpace Holdings, Inc. (MEDP)?
- The TTM average P/S ratio for MEDP stock is 6.09.
- What is the 3Y average P/S ratio for Medpace Holdings, Inc. (MEDP)?
- The 3Y average P/S ratio for MEDP stock is 5.64.
- What is the 5Y average P/S ratio for Medpace Holdings, Inc. (MEDP)?
- The 5Y average P/S ratio for MEDP stock is 5.45.
- What is the 10Y average P/S ratio for Medpace Holdings, Inc. (MEDP)?
- The 10Y average P/S ratio for MEDP stock is 4.64.
Medpace Holdings, Inc. PS Ratio History
| DATE | PS RATIO |
|---|---|
| 2026-06-18 | 4.98 |
| 2026-06-17 | 4.94 |
| 2026-06-16 | 4.99 |
| 2026-06-15 | 5.06 |
| 2026-06-12 | 5.05 |
| 2026-06-11 | 5.14 |
| 2026-06-10 | 5.04 |
| 2026-06-09 | 5.05 |
| 2026-06-08 | 4.95 |
| 2026-06-05 | 4.91 |
| 2026-06-04 | 4.96 |
| 2026-06-03 | 4.88 |
| 2026-06-02 | 4.82 |
| 2026-06-01 | 4.88 |
| 2026-05-29 | 4.83 |
| 2026-05-28 | 4.85 |
| 2026-05-27 | 4.63 |
| 2026-05-26 | 4.64 |
| 2026-05-22 | 4.68 |
| 2026-05-21 | 4.65 |
| 2026-05-20 | 4.56 |
| 2026-05-19 | 4.54 |
| 2026-05-18 | 4.55 |
| 2026-05-15 | 4.49 |
| 2026-05-14 | 4.53 |
| 2026-05-13 | 4.58 |
| 2026-05-12 | 4.54 |
| 2026-05-11 | 4.51 |
| 2026-05-08 | 4.59 |
| 2026-05-07 | 4.64 |
| 2026-05-06 | 4.62 |
| 2026-05-05 | 4.65 |
| 2026-05-04 | 4.51 |
| 2026-05-01 | 4.52 |
| 2026-04-30 | 4.53 |
| 2026-04-29 | 4.47 |
| 2026-04-28 | 4.43 |
| 2026-04-27 | 4.56 |
| 2026-04-24 | 4.44 |
| 2026-04-23 | 4.25 |
| 2026-04-22 | 5.82 |
| 2026-04-21 | 5.89 |
| 2026-04-20 | 6.05 |
| 2026-04-17 | 5.96 |
| 2026-04-16 | 5.90 |
| 2026-04-15 | 5.94 |
| 2026-04-14 | 5.95 |
| 2026-04-13 | 5.74 |
| 2026-04-10 | 5.65 |
| 2026-04-09 | 5.74 |
| 2026-04-08 | 5.96 |
| 2026-04-07 | 5.82 |
| 2026-04-06 | 5.68 |
| 2026-04-02 | 5.70 |
| 2026-04-01 | 5.60 |
| 2026-03-31 | 5.50 |
| 2026-03-30 | 5.27 |
| 2026-03-27 | 5.16 |
| 2026-03-26 | 5.34 |
| 2026-03-25 | 5.34 |
| 2026-03-24 | 5.27 |
| 2026-03-23 | 5.23 |
| 2026-03-20 | 5.18 |
| 2026-03-19 | 5.28 |
| 2026-03-18 | 5.21 |
| 2026-03-17 | 5.21 |
| 2026-03-16 | 5.19 |
| 2026-03-13 | 5.16 |
| 2026-03-12 | 5.08 |
| 2026-03-11 | 5.47 |
| 2026-03-10 | 5.34 |
| 2026-03-09 | 5.48 |
| 2026-03-06 | 5.39 |
| 2026-03-05 | 5.37 |
| 2026-03-04 | 5.33 |
| 2026-03-03 | 5.33 |
| 2026-03-02 | 5.24 |
| 2026-02-27 | 5.17 |
| 2026-02-26 | 5.12 |
| 2026-02-25 | 5.01 |
| 2026-02-24 | 5.06 |
| 2026-02-23 | 5.09 |
| 2026-02-20 | 5.19 |
| 2026-02-19 | 5.11 |
| 2026-02-18 | 5.11 |
| 2026-02-17 | 4.90 |
| 2026-02-13 | 4.90 |
| 2026-02-12 | 4.76 |
| 2026-02-11 | 4.85 |
| 2026-02-10 | 5.11 |
| 2026-02-09 | 6.68 |
| 2026-02-06 | 6.83 |
| 2026-02-05 | 6.82 |
| 2026-02-04 | 7.07 |
| 2026-02-03 | 7.16 |
| 2026-02-02 | 7.41 |
| 2026-01-30 | 7.34 |
| 2026-01-29 | 7.47 |
| 2026-01-28 | 7.53 |
| 2026-01-27 | 7.59 |
| 2026-01-26 | 7.58 |
| 2026-01-23 | 7.41 |
| 2026-01-22 | 7.64 |
| 2026-01-21 | 7.82 |
| 2026-01-20 | 7.59 |
| 2026-01-16 | 7.70 |
| 2026-01-15 | 7.79 |
| 2026-01-14 | 7.77 |
| 2026-01-13 | 7.66 |
| 2026-01-12 | 7.55 |
| 2026-01-09 | 7.50 |
| 2026-01-08 | 7.56 |
| 2026-01-07 | 7.72 |
| 2026-01-06 | 7.67 |
| 2026-01-05 | 7.39 |
| 2026-01-02 | 7.19 |
| 2025-12-31 | 7.08 |
| 2025-12-30 | 7.17 |
| 2025-12-29 | 7.18 |
| 2025-12-26 | 7.15 |
| 2025-12-24 | 7.20 |
| 2025-12-23 | 7.18 |
| 2025-12-22 | 7.20 |
| 2025-12-19 | 7.16 |
| 2025-12-18 | 7.06 |
| 2025-12-17 | 7.02 |
| 2025-12-16 | 7.04 |
| 2025-12-15 | 7.04 |
| 2025-12-12 | 7.03 |
| 2025-12-11 | 7.13 |
| 2025-12-10 | 7.06 |
| 2025-12-09 | 6.85 |
| 2025-12-08 | 6.92 |
| 2025-12-05 | 6.91 |
| 2025-12-04 | 6.86 |
| 2025-12-03 | 7.26 |
| 2025-12-02 | 7.35 |
| 2025-12-01 | 7.41 |
| 2025-11-28 | 7.46 |
| 2025-11-26 | 7.64 |
| 2025-11-25 | 7.71 |
| 2025-11-24 | 7.79 |
| 2025-11-21 | 7.46 |
| 2025-11-20 | 7.38 |
| 2025-11-19 | 7.46 |
| 2025-11-18 | 7.43 |
| 2025-11-17 | 7.38 |
| 2025-11-14 | 7.43 |
| 2025-11-13 | 7.45 |
| 2025-11-12 | 7.53 |
| 2025-11-11 | 7.59 |
| 2025-11-10 | 7.56 |
| 2025-11-07 | 7.42 |
| 2025-11-06 | 7.46 |
| 2025-11-05 | 7.54 |
| 2025-11-04 | 7.49 |
| 2025-11-03 | 7.48 |
| 2025-10-31 | 7.37 |
| 2025-10-30 | 7.31 |
| 2025-10-29 | 7.36 |
| 2025-10-28 | 7.31 |
| 2025-10-27 | 7.51 |
| 2025-10-24 | 7.62 |
| 2025-10-23 | 7.52 |
| 2025-10-22 | 7.39 |
| 2025-10-21 | 7.37 |
| 2025-10-20 | 7.36 |
| 2025-10-17 | 7.14 |
| 2025-10-16 | 7.04 |
| 2025-10-15 | 6.95 |
| 2025-10-14 | 6.99 |
| 2025-10-13 | 7.13 |
| 2025-10-10 | 6.77 |
| 2025-10-09 | 7.01 |
| 2025-10-08 | 7.18 |
| 2025-10-07 | 7.19 |
| 2025-10-06 | 7.17 |
| 2025-10-03 | 7.20 |
| 2025-10-02 | 7.25 |
| 2025-10-01 | 7.35 |
| 2025-09-30 | 6.95 |
| 2025-09-29 | 6.77 |
| 2025-09-26 | 6.71 |
| 2025-09-25 | 6.60 |
| 2025-09-24 | 6.72 |
| 2025-09-23 | 6.71 |
| 2025-09-22 | 6.73 |
| 2025-09-19 | 6.74 |
| 2025-09-18 | 6.78 |
| 2025-09-17 | 6.73 |
| 2025-09-16 | 6.63 |
| 2025-09-15 | 6.71 |
| 2025-09-12 | 6.63 |
| 2025-09-11 | 6.73 |
| 2025-09-10 | 6.44 |
| 2025-09-09 | 6.56 |
| 2025-09-08 | 6.65 |
| 2025-09-05 | 6.58 |
| 2025-09-04 | 6.52 |
| 2025-09-03 | 6.50 |
| 2025-09-02 | 6.40 |
| 2025-08-29 | 6.43 |
| 2025-08-28 | 6.39 |
| 2025-08-27 | 6.40 |
| 2025-08-26 | 6.34 |
| 2025-08-25 | 6.31 |
| 2025-08-22 | 6.27 |
| 2025-08-21 | 6.13 |
| 2025-08-20 | 6.29 |
| 2025-08-19 | 6.25 |
| 2025-08-18 | 6.26 |
| 2025-08-15 | 6.19 |
| 2025-08-14 | 6.20 |
| 2025-08-13 | 6.33 |
| 2025-08-12 | 6.21 |
| 2025-08-11 | 6.08 |
| 2025-08-08 | 5.87 |
| 2025-08-07 | 5.80 |
| 2025-08-06 | 5.82 |
| 2025-08-05 | 5.90 |
| 2025-08-04 | 5.84 |
| 2025-08-01 | 5.72 |
| 2025-07-31 | 5.77 |
| 2025-07-30 | 5.92 |
| 2025-07-29 | 6.05 |
| 2025-07-28 | 6.12 |
| 2025-07-25 | 6.05 |
| 2025-07-24 | 6.16 |
| 2025-07-23 | 5.91 |
| 2025-07-22 | 6.46 |
| 2025-07-21 | 4.47 |
| 2025-07-18 | 4.51 |
| 2025-07-17 | 4.62 |
| 2025-07-16 | 4.55 |
| 2025-07-15 | 4.52 |
| 2025-07-14 | 4.63 |
| 2025-07-11 | 4.68 |
| 2025-07-10 | 4.75 |
| 2025-07-09 | 4.64 |
| 2025-07-08 | 4.67 |
| 2025-07-07 | 4.61 |
| 2025-07-03 | 4.65 |
| 2025-07-02 | 4.72 |
| 2025-07-01 | 4.64 |
| 2025-06-30 | 4.54 |
| 2025-06-27 | 4.49 |
| 2025-06-26 | 4.44 |
| 2025-06-25 | 4.50 |
| 2025-06-24 | 4.56 |
| 2025-06-23 | 4.46 |
| 2025-06-20 | 4.48 |
| 2025-06-18 | 4.38 |
| 2025-06-17 | 4.31 |
| 2025-06-16 | 4.35 |
| 2025-06-13 | 4.31 |
| 2025-06-12 | 4.40 |
| 2025-06-11 | 4.37 |
| 2025-06-10 | 4.42 |
| 2025-06-09 | 4.32 |
| 2025-06-06 | 4.29 |
Showing the most recent 260 of 2,477 data points. The chart above shows the full history.
Related Metrics
About Medpace Holdings, Inc.
Medpace Holdings, Inc., founded in Cincinnati, Ohio, in 1992, functions as a contract research organization (CRO) delivering clinical development and research services. The company assists pharmaceutical, biotechnology, and medical device clients throughout North America, Europe, and Asia. Its comprehensive suite of offerings covers the entire product lifecycle, from initial Phase I trials through to Phase IV post-market surveillance. Medpace's services include designing development programs, coordinating central laboratory functions, managing projects, navigating regulatory processes, overseeing clinical trials, handling data management and analytics, ensuring pharmacovigilance, aiding with new drug application submissions, and providing ongoing post-marketing clinical support. Furthermore, the company offers specialized bio-analytical laboratory testing, conducts clinical human pharmacology studies, provides imaging services, and delivers expert electrocardiography (ECG) reading for clinical research.
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- August James Troendle